Neelkanth Drugs Private Limited - Company Profile

It is a pharma private limited company based in Ameerpet, Telangana, India, established in 1999.
1999 Ameerpet, Telangana, India Amalgamated
Last Updated:
Access Report
About Neelkanth Drugs Private Limited

Neelkanth Drugs Private Limited, a amalgamated private limited company, was established on 19 April 1999 in Ameerpet, Telangana, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24233TS1999PTC173960. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹2.90 Cr.

It upholds a compliant status. Employing 467 professional, Its leadership includes Arvind Kumar Venkat (Nominee Director), Vardaan Sharma (Director), Yashwant Singh (Nominee Director). Past directors included Arvind Kumar Venkat, Taruna Chimanlal Joshi, Ved Prakash Saini. It holds no open charges and ₹213.59 Cr settled loans. Its latest AGM occurred on 09 August 2023, with the balance sheet filed on 31 March 2023. It is based at D.No 7-2-1740, K,Subbaiah Pillai, Godowns, Main Road,Sanath Nagar, Ameerpet, Telangana, 500018.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24233TS1999PTC173960

  • Registration Number

    173960

  • Incorporation Date

    19 April 1999

  • Authorized Capital

    ₹3.00 Cr

  • Paid-Up Capital

    ₹2.90 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Amalgamated

Key Metrics
  • Authorised Capital ₹ 3.00 Cr
  • Paid Up Capital ₹ 2.90 Cr
  • Company Age 26 Year, 10 Months
  • Last Filing with ROC 31 Mar 2023
  • Satisfied Charges ₹ 213.59 Cr
  • Revenue Growth **** 38.28%
  • Profit Growth **** -44.75%
  • Ebitda **** 26.08%
  • Net Worth 0.55%
  • Total Assets -78.19%
Company report

Neelkanth Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Neelkanth Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Neelkanth Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Arvind Kumar Venkat Nominee Director 29 Jun 2011 Current
Vardaan Sharma Director 31 Aug 2017 Current
Yashwant Singh Nominee Director 31 Jul 2018 Current
Pramod Kumar Sharma Managing Director 15 Oct 2004 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 29 Jan 2020 Past
Pramod Abcsdd Director 03 May 2018 Past
Pramod Abcsdd Director 31 Aug 2017 Past
Pramod Abcsdd Director 29 Jun 2011 Past
Pramod Abcsdd Director 29 Jun 2011 Past
Pramod Abcsdd Director 01 Apr 2011 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Neelkanth Drugs.

Neelkanth Drugs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 38.28% increase. The company also saw a substantial fall in profitability, with a 44.75% decrease in profit. The company's net worth moved up by a moderate rise of 0.55%.

Neelkanth Drugs revenue growth over time
Neelkanth Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 38.28%
*******
*******
*******
*******
Revenue from Operations
*******
 38.31%
*******
*******
*******
*******
Total Assets
*******
 -78.19%
*******
*******
*******
*******
Profit or Loss
*******
 -44.75%
*******
*******
*******
*******
Net Worth
*******
 0.55%
*******
*******
*******
*******
EBITDA
*******
 26.08%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Neelkanth Drugs?

In 2022, Neelkanth Drugs had a promoter holding of 100.00%. The company had 2 Subsidiaries and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹2,135,940,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 136.63 Cr
  • Others : 50.28 Cr
  • Kotak Mahindra Bank Limited : 15.00 Cr
  • The Nainital Bank Limited : 11.68 Cr
Latest Charge Details
Date Lender Amount Status
29 Jun 2020 Hdfc Bank Limited ₹90.00 Cr Satisfied
20 Dec 2018 Others ₹50.00 Cr Satisfied
16 Sep 2017 Hdfc Bank Limited ₹6.30 M Satisfied
30 Jun 2017 Others ₹2.82 M Satisfied
20 Nov 2014 Hdfc Bank Limited ₹1.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Neelkanth Drugs?

Neelkanth Drugs has a workforce of 467 employees as of May 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Neelkanth Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neelkanth Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Neelkanth Drugs
Recent Activity within the Organization
  • Charges

    Progress on A charge registered on 12 Aug 2011 via Charge ID 10309932 with The Nainital Bank Limited was fully satisfied on 18 Dec 2023. was documented.

  • Charges

    Progress on A charge registered on 16 Sep 2017 via Charge ID 100144950 with Hdfc Bank Limited was fully satisfied on 16 Dec 2023. was documented.

  • Charges

    Progress on A charge registered on 30 Jun 2017 via Charge ID 100141906 with Others was fully satisfied on 13 Dec 2023. was documented.

  • Annual General Meeting

    The activity Neelkanth Drugs Private Limited last Annual general meeting of members was held on 09 Aug 2023 as per latest MCA records. was completed.

  • Charges

    Progress on A charge registered on 29 Jun 2020 via Charge ID 100346758 with Hdfc Bank Limited was fully satisfied on 03 Aug 2023. was documented.

  • Balance Sheet

    The activity Neelkanth Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Neelkanth Drugs Private Limited?

The CIN of Neelkanth Drugs Private Limited is U24233TS1999PTC173960.

Where is Neelkanth Drugs Private Limited headquartered?

Neelkanth Drugs Private Limited is headquartered at D.No 7-2-1740, K,Subbaiah Pillai, Godowns, Main Road,Sanath Nagar, Ameerpet, Telangana, 500018.

When was Neelkanth Drugs Private Limited incorporated?

Neelkanth Drugs Private Limited was incorporated on 19 April 1999.

Who are the current directors of Neelkanth Drugs Private Limited?

The current directors of Neelkanth Drugs Private Limited are

What is the primary industry of Neelkanth Drugs Private Limited?

The primary industry of Neelkanth Drugs Private Limited is Trade.

Is Neelkanth Drugs Private Limited a listed company?

Neelkanth Drugs Private Limited is unlisted.

What is the capital structure of Neelkanth Drugs Private Limited?

The authorized capital of Neelkanth Drugs Private Limited is ₹3.00 Cr, and the paid-up capital is ₹2.90 Cr.

What is the compliance status of Neelkanth Drugs Private Limited?

The compliance status of Neelkanth Drugs Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available